As lipoproteins were regulated by apolipoprotein, our findings suggest that apoC-II and apoC-III are closely related to CV risk markers in early-stage childhood CKD, which may precede impaired lipoprotein metabolism, as evaluated by alterations in lipid profiles. Here, APOC2 is linked to chronic kidney disease.